http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109750063-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H6-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H5-00
filingDate 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109750063-B
titleOfInvention CRISPR _ Cas9 vector construction of histone deacetylase gene HDA19 and application thereof
abstract The invention relates to the field of kenaf molecular breeding, in particular to construction and application of a CRISPR _ Cas9 vector of histone deacetylase gene HDA 19. The vector is a T1-sgRNA expression cassette, a T2-sgRNA expression cassette and a T3-sgRNA expression cassette which insert three target points of kenaf HDA19 gene on a vector pYLCRISPR-Cas9 Pubi-H. According to the principle of designing targets by the CRISPR _ Cas9 technology, the invention designs three targets on three exons of the kenaf HDA19 gene, successfully constructs a pYLCRISPR-Cas9Pubi-H-HDA19 vector, and provides a basis for researching the effect of the HDA19 gene in kenaf male sterility generation and regulation and control mechanisms of salt, drought and other adversity stresses. The invention provides a theoretical basis for the research on the molecular mechanism of regulating the generation of the male sterility of the kenaf by histone acetylation, and provides feasibility for creating a male sterility material by utilizing an engineering technology in the future.
priorityDate 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502593
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491955
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743192
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17198
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510698
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38103
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664

Total number of triples: 40.